Delivery Order SPE2DB22D2206-SPE2DB25FJM48
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used for serious systemic fungal infections. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a specialized pharmaceutical product used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $11,016.77, was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,975.20 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559476979 AMBISOME 50 MG VIALS. This contract has an ultimate completion date of January 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AMBISOME 50 MG VIALS. The delivery order has a potential value of $1,923.48 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the Department of Defense, providing pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,846.96 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,153,581 units of AMBISOME 50 MG VIALS by December 21, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a long history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order was not set aside and is part of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBISOME 50 MG VIALS, a pharmaceutical product, with a ceiling value of $16,215.34 and a period of performance through July 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,035.68 order is for the delivery of AMBISOME 50 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 2, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,923.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2023. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen...